Seeking transpaRINcy for rituximab dosing in NMOSD - Authors' reply.
Saved in:
| Title: | Seeking transpaRINcy for rituximab dosing in NMOSD - Authors' reply. |
|---|---|
| Authors: | Tahara M; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto 616-8255, Japan. Electronic address: tahara.masayuki.ne@mail.hosp.go.jp., Oeda T; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto 616-8255, Japan., Sawada H; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto 616-8255, Japan. |
| Source: | The Lancet. Neurology [Lancet Neurol] 2020 Sep; Vol. 19 (9), pp. 716-717. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 101139309 Publication Model: Print Cited Medium: Internet ISSN: 1474-4465 (Electronic) Linking ISSN: 14744422 NLM ISO Abbreviation: Lancet Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1474-4465 |
|---|---|
| DOI: | 10.1016/S1474-4422(20)30281-7 |
